About this policy
The comment period for the MolDX: Minimal Residual Disease Testing for Cancer DL38779 Local Coverage Determination (LCD) began on 9/24/20 and ended on 11/7/2020. The notice period for L38779 begins on 11/11/2021 and will become effective on 12/26/2021. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.